
- 1D
- 1W
- 1M
- 1Y
- 5Y
- YTD
About Avidity Biosciences
Avidity Biosciences LLC operates as a biotechnology company. The Company develops and discovers novel antibody oligonucleotide conjugates therapeutics that overcome current barriers to the delivery of oligonucleotides and unlock their potential to treat a wide range of serious diseases. Avidity Biosciences serves customers in the United States.
Stock Analysis

last close
$12.87
1-mo return
-27.2%
3-mo return
-13.8%
avg daily vol.
266.8T
52-week high
29.59
52-week low
11.02
market cap.
$644M
forward pe
-
annual div.
-
roe
-38.8%
ltg forecast
-
dividend yield
-
annual rev.
$8M
inst own.
95.5%